Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 36
|
BSPED2014
|
Next issue
42nd Meeting of the British Society for Paediatric Endocrinology and Diabetes
All volumes
0105 UKINETS2024
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
eposters
Abstracts
Contents
Speaker Abstracts
CME Session
Endocrine tumours
ea0036cme1
Surgery of endocrine tumour
ea0036cme2
The late effects of treatment for childhood cancer
ea0036cme3
Female contraception and reproductive endocrinology
ea0036cme4
Infertility and infertility management
ea0036cme5
Trainees update
ea0036cme6
Main Symposia
Plenary Guest Lecture
The future of the child with T1DM
ea0036pl1
Symposia 1 Controversies in Vitamin D deficiency
Consequences of maternal vitamin D deficiency
ea0036s1.1
The role of vitamin D deficiency in unexplained fractures of infancy
ea0036s1.2
Strategies for prophylaxis and treatment of vitamin D deficiency
ea0036s1.3
Symposia 2 Recent advances in adrenal disease
Adrenal development and adrenal insufficiency
ea0036s2.1
Curing Addison's disease
ea0036s2.2
Symposia 3 New developments from trials in TIDM
New developments from trials in TIDM: findings from the DECIDE trial
ea0036s3.1
How do the findings from the Hvidore study change practice?
ea0036s3.2
Prevention trials in type 1 diabetes', including an update on the ongoing TRIGR trial
ea0036s3.3
Debate: Children with diabetes should be managed centrally
Children with diabetes should be managed centrally
ea0036d1.1
Children with diabetes should be managed locally
ea0036d1.2
Diabetes Professionals Session
Paediatric obesity and type 2 diabetes
ea0036dp1
Type 2 diabetes
ea0036dp2
Hypoglycaemia in type 1 diabetes mellitus
ea0036dp3
National Audit Data highlight persistent sub-optimal control among increasing numbers of people living with diabetes with severe consequences for the individual and the NHS
ea0036dp4
School care plans
ea0036dp5
Fat and Protein counting: what's the evidence?
ea0036dp6
BPT
ea0036dp7
Endocrine Nurse Session
Genetics: back to basics
ea0036en1
Breathe-easy - the significance of respiratory assessment in Prader-Willi syndrome
ea0036en2
Sleep easy: the practicalities of sleep study
ea0036en3
Patient experience
ea0036en4
Home grown: PENS vs homecare GH start
ea0036en5
Oral Communications
Oral Communications 1
Paediatric pituitary adenomas: rare, complex, and by no means benign
ea0036oc1.1
Functional adrenal tumour as a cause of virilised infant
ea0036oc1.2
Oral Communications 2
Unilateral gynecomastia: an unusual presentation of Peutz Jegher's syndrome
ea0036oc2.1
Isodicentric chromosome Y mosaicism in a female patient: an indication for gonadectomy
ea0036oc2.2
Oral Communications 3
The Scottish audit of atypical genitalia: first year results
ea0036oc3.1
Vertebral fracture assessment in a paediatric population using dual-energy X-ray absorptiometry
ea0036oc3.2
An analysis of meta-data from three UK centres on the sequelae of paediatric craniopharyngiomas over four decades
ea0036oc3.3
Standard population screening for diabetes mellitus has low sensitivity in identifying diabetes in adult survivors of childhood bone marrow transplantation with total body irradiation
ea0036oc3.4
Statistical prediction of HRpQCT microstructural trabecular parameters using 1.5T skeletal MRI
ea0036oc3.5
A novel non-invasive short Synacthen test
ea0036oc3.6
Patterns of gene expression in pre-pubertal children are associated with the severity of their GH deficiency
ea0036oc3.7
Trends in off-label prescription of GH: results from the National GH Audit
ea0036oc3.8
Physiological dose reverse rhythm testosterone treatment abolishes the development of permanent gynaecomastia in adolescents with 47,XXY Klinefelter syndrome
ea0036oc3.9
Oral Communications 4
Utility of basal LH in comparison to the GnRH test for identifying central precocious puberty in girls
ea0036oc4.1
Validation of a Food Frequency Questionnaire for rapid assessment of daily dietary calcium intake in children
ea0036oc4.2
A role for delta-like homologue 1 in a secretory placental population and implications for fetal growth
ea0036oc4.3
Expression of Sonic hedgehog signalling components in the developing human adrenal cortex
ea0036oc4.4
Adiposity differs by fracture site in children with upper limb fractures
ea0036oc4.5
Evaluating dipeptidyl peptidase-4 expression in patients with diffuse and focal congenital hyperinsulinism.
ea0036oc4.6
Pitfalls in the diagnosis of neonatal adrenal insufficiency
ea0036oc4.7
Recombinant human GH in paediatric inflammatory bowel disease: short term effects on bone biomarkers and long term effects on bone and lean mass
ea0036oc4.8
Neurodevelopmental phenotypes in children with early and late presenting congenital hyperinsulinism
ea0036oc4.9
Oral Communications 5
Congenital adrenal hyperplasia: a survey on the current practice in UK
ea0036oc5.1
The impact of receiving a diagnosis of congenital hypothyroidism on families
ea0036oc5.2
Does treatment with GnRH analogues affect BMI in children with precocious or early puberty?
ea0036oc5.3
Oral Communications 6
Exploring variation in treatment targets across paediatric diabetes units in England and Wales
ea0036oc6.1
The diabetic pregnancy and offspring adiposity in infancy and childhood: a meta-analysis
ea0036oc6.2
Comparison of breath acetone, with blood glucose and blood ketones in children and adolescents with type 1 diabetes
ea0036oc6.3
The role of the AMPK pathway in mediating the effects of metformin on mesenchymal stem cell differentiation
ea0036oc6.4
Capillary beta-hydroxybutyrate levels reliably predicts clinical severity in established diabetes but not in first presentations of type 1 diabetes in children
ea0036oc6.5
Comparison of type 1 diabetic control before and 5 years after transfer to adult services: audit of the 2008 cohort from the Royal Hospital of Sick Children (RHSC), Glasgow
ea0036oc6.6
Oral Communications 7
Additional professional support for paediatric patients with diabetes mellitus: are we targeting the right patients?
ea0036oc7.1
Urinary vitamin E metabolites as a biomarker of oxidative stress in type 1 diabetes
ea0036oc7.2
Do diabetes teams give consistent advice on self-management and does it relate to glycaemic control? Yorkshire and Humber Paediatric Diabetes network survey
ea0036oc7.3
Hyperosmolar hyperglycaemic state: an unusual presentation of type 2 diabetes mellitus in children
ea0036oc7.4
The relationship of vibration perception threshold with metabolic control and duration of disease in British children with type 1 diabetes
ea0036oc7.5
Poster Presentations
(1)
A rare cause of iatrogenic Cushing's syndrome
ea0036P1
A unique case of a child with two inherited salt-losing conditions
ea0036P2
Aldosterone synthase deficiency due to a novel mutation in CYP11B2
ea0036P3
cDNA analysis reveals NNT pseudoexon activation in two siblings with familial glucocorticoid deficiency
ea0036P4
Cerebral oedema: a rare presentation of Addison's disease
ea0036P5
Comparing clinical practice with consensus guidelines for the investigation and management of British children with congenital adrenal hyperplasia
ea0036P6
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a regional cohort 1994-2004: characterisation and genotype-phenotype analysis
ea0036P7
Do babies born to mothers taking antenatal prednisolone require screening for adrenal suppression?
ea0036P8
Functional adrenal tumour as a cause of virilised infant
ea0036P9
Severe hyponatraemia and pseudohypoaldosteronism secondary to infantile atopic dermatitis
ea0036P10
The accuracy of 24-h urinary free cortisol as a screening test in the diagnosis of Cushing's syndrome in children
ea0036P11
Varied clinical presentations of six patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc
ea0036P12
Development of a premature adrenarche management guideline
ea0036P13
Bone mineral density and vertebral compression fractures in patients with recessive dystrophic epidermolysis bullosa
ea0036P14
Hyperostosis-hyperphosphataemia syndrome: shortening a diagnostic odyssey
ea0036P15
Leptin is associated with bone microstructural changes in obese children
ea0036P16
Neonatal seizure: a rare presentation of maternal hyperparathyroidism
ea0036P17
Suppression of bone turnover and its determinants in children receiving bisphosphonate therapy
ea0036P18
Young adults with Klinefelter syndrome and congenital anorchia treated with testosterone from adolescence have normal bone and muscle mass but increased central adiposity
ea0036P19
Denosumab therapy for refractory hypercalcaemia secondary to squamous cell carcinoma of skin
ea0036P20
Hypercalcaemia, hypercalciuria and nephrocalcinosis secondary to a CYP24A1 mutation
ea0036P21
An unusual presentation of eating disorder in type 1 diabetes
ea0036P22
Audit of insulin doses in children with newly diagnosed type 1 diabetes
ea0036P23
Be wary of hyperglycaemia in newborn: a case of monogenic permanent neonatal diabetes
ea0036P24
Bone markers in children with type 1 DM
ea0036P25
Can proportion of children achieving HbA1c below 58 mmol/mol within the first year of diagnosis be used as a standard of quality of care provided for children with type 1 diabetes?
ea0036P26
Children with type 1 diabetes and coeliac disease at Nottingham Children's Hospital: a service review and evaluation
ea0036P27
Diabetes A[amp]E attendances and ward admissions pre and post implementation of an out of hours telephone service
ea0036P28
Does continuous subcutaneous insulin infusion therapy improve diabetic control in a district general hospital population?
ea0036P29
Epidemiology and risk factors for diabetic retinopathy in CYP with type 1 diabetes mellitus in a DGH
ea0036P30
Eruptive xanthomas as a presenting feature of diabetes mellitus
ea0036P31
How effective was the national '4T's' diabetes awareness campaign for a local paediatric population and did specific interventions reduce admissions for DKA?
ea0036P32
Improving the clinical pathway for diabetic retinal screening in paediatric diabetes
ea0036P33
In-patient care for children with type 1 diabetes across hospitals in the Yorkshire and Humber region in the north of England
ea0036P34
Kaempferol, a dietary flavonoid improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes
ea0036P35
Lessons learnt from starting an insulin pump service in Forth Valley, Scotland: challenges, solutions, and outcomes
ea0036P36
Management of paediatric diabetic ketoacidosis: are we doing it right?
ea0036P37
An evaluation of a hospital-based diabetes education program provided for schools and nurseries
ea0036P38
Meeting the training needs of paediatric trainees in managing children with diabetes
ea0036P39
Neonatal diabetes: the great masquerader experiences from one hospital
ea0036P40
Prevalence, clinical profile, and glycemic variability of celiac disease in patients with type 1 diabetes mellitus in western, Uttar Pradesh, India
ea0036P41
Prognostic factors in patients hospitalised with diabetic ketoacidosis
ea0036P42
The effect of the introduction of best practice tariff for paediatric diabetes care on service provision and staffing in the West Midlands
ea0036P43
Transition and beyond in childhood onset type 1 diabetes
ea0036P44
Using an electronic tablet to survey patient satisfaction in an adolescent transitional diabetes clinic at York, United Kingdom
ea0036P45
Visual disturbance in diabetes mellitus: don't be blind to alternatives to retinopathy
ea0036P46
An ovulating testis
ea0036P47
Initial care of babies born with ambiguous genitalia: a service evaluation
ea0036P48
Pubertal gynaecomastia: when is reverse rhythm testosterone treatment in adolescent boys with delayed puberty effective?
ea0036P49
Sex chromosome mosaicism in males: our experience
ea0036P50
What is the optimum cardiovascular screening in Turner syndrome during childhood and adolescence? Is it achievable?
ea0036P51
Improving health-related outcomes for childhood craniopharyngiomas with a modern individualised conservative surgical strategy and adjuvant focussed radiation; experience at a single centre (great ormond street hospital [ndash] GOSH) 2009[ndash]2013
ea0036P52
Bone age study in children (BASIC): a study of the quality of bone age X-rays and an intervention to improve quality and reduce re-X-ray rates
ea0036P53
Transient hyperphosphatemia and hyperparathyroidism in a preterm neonate
ea0036P54
Journey through setup of adolescent gender identity dysphoria service for Notheren Ireland
ea0036P55
Low birth weight is not a feature of polycystic ovarian syndrome in a British cohort of adolescents, but obesity and metabolic syndrome are common associations
ea0036P56
Effect of vitamin D treatment on glucose and insulin metabolism, and bone turnover in children with symptomatic vitamin D deficiency
ea0036P57
An audit of paediatric obesity in secondary care
ea0036P58
Is there a role for medical management in childhood obesity? A review of the Manchester Metabolic Obesity Service
ea0036P59
Melanocortin 2 receptor accessory protein 2 (Mrap2) regulates hypothalamic melanocortin-4-receptor trafficking in vivo
ea0036P60
Challenges of managing a 9-month old child with congenital hyperinsulinism within a secondary care setting
ea0036P61
Lanreotide therapy for congenital hyperinsulinism
ea0036P62
Hyperinsulinaemic hypoglycaemia and cochlear hypoplasia in a rare case of Pallister-Hall syndrome
ea0036P63
Cellular proliferation is increased in both the lesion and non-lesion pancreas in focal congenital hyperinsulinism
ea0036P64
A heterozygous STAT5B variant in a family with short stature and transient hyperprolactinaemia: a possible dominant negative effect
ea0036P65
Growth characteristics in children with Temple syndrome: an under-diagnosed imprinting disorder
ea0036P66
A rare thyrotropinoma complicated by cerebral salt wasting: a case report
ea0036P67
Assessing the diagnostic value of testosterone, basal LH and LHRH test in predicting pubertal progression in boys
ea0036P68
Bone mass and body composition in adolescents with childhood onset GH deficiency
ea0036P69
Evaluating the diagnostic value of basal LH and LHRH test in predicting progression into precocious puberty in girls
ea0036P70
A novel de novo heterozygous mutation in FGFR1 is associated with Hartsfield syndrome
ea0036P71
'Can I gain a greater height?': a case of metaphyseal chondrodysplasia, Schmid-type
ea0036P72
GH deficiency contributes to short stature in children with chromosome 18 rearrangements
ea0036P73
Impaired insulin and IGF2 signalling in the primordial growth disorder 3-M syndrome
ea0036P74
Relationship between IGF1 concentration and growth velocity in infants and toddlers
ea0036P75
Septo-optic dysplasia, multiple pituitary hormone deficiency and optic nerve hypoplasia: clinical and neuroradiological characteristics
ea0036P76
Thickened pituitary stalk (TPS) and/or idiopathic central diabetes insipidus (ICDI): a single centre experience of occult causative pathology evolving in 54 children over 30 years
ea0036P77
Three year experience of a national interdisciplinary initiative to improve outcomes for children with hypothalamic pituitary axis tumours (HPATs) using multi-site videoconferencing for decision making on Behalf of the UK HPAT Interest Group
ea0036P78
UK GH stimulation test survey
ea0036P79
Variable presentation of xanthogranulomatous hypophysitis: a case series
ea0036P80
A case report of TR[beta] mutation leading to raised T4 levels presenting with abnormal body habitus
ea0036P81
An audit to assess the impact of increasing the borderline blood spot TSH cut-off on the detection of cases of congenital hypothyroidism (CHT) identified via newborn screening
ea0036P82
Congenital central hypothyroidism due to a TSHB mutation with uniparental inheritance
ea0036P83
Delayed recognition of neonatal thyrotoxicosis in a baby born to a mother previously treated for Grave's disease
ea0036P84
Goitre: a presenting feature of acute myeloid leukaemia
ea0036P85
Management of congenital hypothyroidism: audit of our experience over a decade vs the new national standards
ea0036P86
Prevalence of short stature in juvenile hypothyroidism and the impact of treatment in a tertiary care center
ea0036P87
Severe hypothyroidism developing in an infant with hepatoblastoma and Beckwith-Wiedemann syndrome: could there be a link?
ea0036P88